Research

We develop and apply statistical and causal methods for pharmacovigilance and post-marketing vaccine safety surveillance. Our work focuses on detecting adverse events, characterizing temporal risk patterns, and addressing confounding and reporting biases in large observational and surveillance data sources. These methods support regulatory decision making and real-time safety monitoring at population scale.